Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

beta-alanine dipeptides as MC4R agonists.

Réjean Ruel¹, Timothy F Herpin, Lawrence Iben

¹Bristol-Myers Squibb Pharmaceutical Research Institute, 100 boul. de l'Industrie, Candiac, Quebec, Canada J5R 1J1. rejean.ruel@bms.com

Bioorganic & Medicinal Chemistry Letters

|December 4, 2003

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Interpretable machine learning for preoperative prediction of ground-glass nodules invasiveness in lung adenocarcinoma: a multicenter study.

Scientific reports·2026

Same author

Accurate prediction of mortality in children with sepsis: development and validation of an explainable model based on real-world data.

Italian journal of pediatrics·2026

Same author

Dual-energy CT-derived fibrosis biomarkers predict pancreatic fistula after pancreaticoduodenectomy: a collagen proportional area mediation analysis.

European journal of radiology·2026

Same author

Development and Evaluation of a Web-Based App for Adverse Effect Management in Breast Cancer Patients Treated with Oral Targeted Therapy or Chemotherapy: Findings from a Pilot Study.

Current oncology (Toronto, Ont.)·2026

Same author

Clinical management of metastatic gastric tumors: a case report of right popliteal leiomyosarcoma metastasizing to the stomach and literature review.

Frontiers in oncology·2026

Same author

Supervised machine learning models for predicting sepsis-associated acute kidney injury in children: a real-world evaluation.

World journal of pediatrics : WJP·2026

Same journal

Identification of TYK2 activators. Part 2: Optimization of terminal alkyne substituents to enhance activation potency.

Bioorganic & medicinal chemistry letters·2026

Same journal

Synthesis and biological investigation of phenothiazine-based derivatives as potential HDAC6 inhibitors for treatment of glioblastoma multiforme.

Bioorganic & medicinal chemistry letters·2026

Same journal

Solid-phase synthesis and antimicrobial activities of lipid-neomycin conjugates.

Bioorganic & medicinal chemistry letters·2026

Same journal

Discovery of a potent sGC stimulator with once-daily dosing potential for the treatment of hypertension.

Bioorganic & medicinal chemistry letters·2026

Same journal

OracleScreen-LILRB4 (HTS-Oracle v3): machine learning-guided discovery of myeloid immune checkpoint binders validated in patient-derived cells.

Bioorganic & medicinal chemistry letters·2026

Same journal

Rational design and N-terminal acylation of a lactam-cyclized 11-residue antimicrobial peptide for improved antibacterial potency.

Bioorganic & medicinal chemistry letters·2026

See all related articles

Researchers identified a beta-Alanine derivative 2 as a potent agonist for melanocortin 4 receptor (MC4R). This finding is significant for understanding MC4R function and developing related therapeutics.

Area of Science:

Medicinal Chemistry
Pharmacology
Endocrinology

Background:

The melanocortin 4 receptor (MC4R) plays a crucial role in regulating energy homeostasis and appetite.
Dysfunction of MC4R signaling is implicated in obesity and metabolic disorders.

Purpose of the Study:

To discover and characterize novel potent agonists of the melanocortin 4 receptor (MC4R).
To explore the structure-activity relationships of beta-Alanine derivatives as MC4R modulators.

Main Methods:

Synthesis of a series of beta-Alanine derivatives.
In vitro evaluation of compound potency using MC4R binding and functional assays.
Determination of half-maximal inhibitory concentration (IC50) values.

Main Results:

Related Experiment Videos

Beta-Alanine derivative 2 demonstrated high potency as an MC4R agonist, with an IC(50) of 16 nM.
Related compounds also exhibited significant MC4R agonist activity, suggesting a promising chemical scaffold.

Conclusions:

Beta-Alanine derivative 2 represents a potent MC4R agonist with potential therapeutic applications.
The identified compounds provide valuable tools for further investigation of MC4R pathways in metabolic regulation.